Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
237M
-
Number of holders
-
65
-
Total 13F shares, excl. options
-
41.8M
-
Shares change
-
-1.18M
-
Total reported value, excl. options
-
$47.3M
-
Value change
-
-$1.97M
-
Put/Call ratio
-
6.64
-
Number of buys
-
24
-
Number of sells
-
-39
-
Price
-
$1.13
Significant Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q3 2021
91 filings reported holding ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK as of Q3 2021.
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 41.8M shares
of 237M outstanding shares and own 17.64% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (13.3M shares), Nuveen Asset Management, LLC (6.88M shares), VANGUARD GROUP INC (5.72M shares), BOOTHBAY FUND MANAGEMENT, LLC (3.13M shares), BlackRock Inc. (2.35M shares), GEODE CAPITAL MANAGEMENT, LLC (1.31M shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (1.2M shares), Magnetar Financial LLC (811K shares), Clearline Capital LP (747K shares), and MORGAN STANLEY (638K shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.